Literature DB >> 22563080

Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).

Eva Bentmann1, Manuela Neumann, Sabina Tahirovic, Ramona Rodde, Dorothee Dormann, Christian Haass.   

Abstract

Cytoplasmic inclusions containing TAR DNA-binding protein of 43 kDa (TDP-43) or Fused in sarcoma (FUS) are a hallmark of amyotrophic lateral sclerosis (ALS) and several subtypes of frontotemporal lobar degeneration (FTLD). FUS-positive inclusions in FTLD and ALS patients are consistently co-labeled with stress granule (SG) marker proteins. Whether TDP-43 inclusions contain SG markers is currently still debated. We determined the requirements for SG recruitment of FUS and TDP-43 and found that cytoplasmic mislocalization is a common prerequisite for SG recruitment of FUS and TDP-43. For FUS, the arginine-glycine-glycine zinc finger domain, which is the protein's main RNA binding domain, is most important for SG recruitment, whereas the glycine-rich domain and RNA recognition motif (RRM) domain have a minor contribution and the glutamine-rich domain is dispensable. For TDP-43, both the RRM1 and the C-terminal glycine-rich domain are required for SG localization. ALS-associated point mutations located in the glycine-rich domain of TDP-43 do not affect SG recruitment. Interestingly, a 25-kDa C-terminal fragment of TDP-43, which is enriched in FTLD/ALS cortical inclusions but not spinal cord inclusions, fails to be recruited into SG. Consistently, inclusions in the cortex of FTLD patients, which are enriched for C-terminal fragments, are not co-labeled with the SG marker poly(A)-binding protein 1 (PABP-1), whereas inclusions in spinal cord, which contain full-length TDP-43, are frequently positive for this marker protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22563080      PMCID: PMC3391091          DOI: 10.1074/jbc.M111.328757

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Stress granule assembly is mediated by prion-like aggregation of TIA-1.

Authors:  Natalie Gilks; Nancy Kedersha; Maranatha Ayodele; Lily Shen; Georg Stoecklin; Laura M Dember; Paul Anderson
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

2.  Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons.

Authors:  T Sato; S Takeuchi; A Saito; W Ding; H Bamba; H Matsuura; Y Hisa; I Tooyama; M Urushitani
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

3.  The seeds of neurodegeneration: prion-like spreading in ALS.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

Review 4.  Conserved structures and diversity of functions of RNA-binding proteins.

Authors:  C G Burd; G Dreyfuss
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

5.  TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor.

Authors:  Colleen M Dewey; Basar Cenik; Chantelle F Sephton; Daniel R Dries; Paul Mayer; Shannon K Good; Brett A Johnson; Joachim Herz; Gang Yu
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

Review 6.  RNA-binding proteins with prion-like domains in ALS and FTLD-U.

Authors:  Aaron D Gitler; James Shorter
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

7.  Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.

Authors:  Edor Kabashi; Li Lin; Miranda L Tradewell; Patrick A Dion; Valérie Bercier; Patrick Bourgouin; Daniel Rochefort; Samar Bel Hadj; Heather D Durham; Christine Vande Velde; Guy A Rouleau; Pierre Drapeau
Journal:  Hum Mol Genet       Date:  2009-12-03       Impact factor: 6.150

8.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

9.  Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases.

Authors:  Yoshiaki Furukawa; Kumi Kaneko; Gen Matsumoto; Masaru Kurosawa; Nobuyuki Nukina
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

10.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

View more
  130 in total

1.  Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43.

Authors:  Koji Matsukawa; Tadafumi Hashimoto; Taisei Matsumoto; Ryoko Ihara; Takahiro Chihara; Masayuki Miura; Tomoko Wakabayashi; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes.

Authors:  Arianna Russo; Raffaella Scardigli; Federico La Regina; Melissa E Murray; Nicla Romano; Dennis W Dickson; Benjamin Wolozin; Antonino Cattaneo; Marcello Ceci
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

Review 3.  Age-related neurodegenerative diseases.

Authors:  Michael Duggan; Bahareh Torkzaban; Taha Mohseni Ahooyi; Kamel Khalili; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2019-09-25       Impact factor: 6.384

4.  Liquid-Liquid Phase Separation in Physiology and Pathophysiology of the Nervous System.

Authors:  Yasunori Hayashi; Lenzie K Ford; Luana Fioriti; Leeanne McGurk; Mingjie Zhang
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

Review 5.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

Review 6.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 7.  MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.

Authors:  Paola Rinchetti; Mafalda Rizzuti; Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

8.  Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis.

Authors:  Yoshitaka Tashiro; Makoto Urushitani; Haruhisa Inoue; Masato Koike; Yasuo Uchiyama; Masaaki Komatsu; Keiji Tanaka; Maya Yamazaki; Manabu Abe; Hidemi Misawa; Kenji Sakimura; Hidefumi Ito; Ryosuke Takahashi
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.

Authors:  J Gavin Daigle; Nicholas A Lanson; Rebecca B Smith; Ian Casci; Astha Maltare; John Monaghan; Charles D Nichols; Dmitri Kryndushkin; Frank Shewmaker; Udai Bhan Pandey
Journal:  Hum Mol Genet       Date:  2012-12-20       Impact factor: 6.150

10.  Cytoplasmic RNA Granules and Viral Infection.

Authors:  Wei-Chih Tsai; Richard E Lloyd
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.